NCT00321165View on ClinicalTrials.gov

The AOT (Acridine Orange and Taurolidine) Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Parenteral NutritionInfectionSepsis
Interventions
DRUG

taurolidine

Trial Locations (1)

6500 HB

Department of Gastroenterology and Hepatology clinical ward, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT00321165 - The AOT (Acridine Orange and Taurolidine) Trial | Biotech Hunter | Biotech Hunter